AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. BABA
7. AVGO
8. SPCX
9. BJ
10. NTES

Go back to AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
(NASDAQ: ACIU) Delayed: 2.90 +0.26 (9.85%)
Previous Close $2.64    52 Week High $19.97 
Open $2.66    52 Week Low $10.36 
Day High $2.95    P/E N/A 
Day Low $2.65    EPS $0.00 
Volume 442,011